TY - JOUR
T1 - Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms Report from the 2021 SH/EAHP workshop
AU - Amador, Catalina
AU - Cook, James R.
AU - Czader, Magdalena
AU - Duffield, Amy
AU - Goodlad, John
AU - Nejati, Reza
AU - Ott, German
AU - Xiao, Wenbin
AU - Dave, Sandeep
AU - Wasik, Mariusz A.
AU - Dogan, Ahmet
N1 - Publisher Copyright:
© the author(s) 2023. published by oxford University press on behalf of american society for clinical pathology. all rights reserved.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Objectives: Sessions 8 and 9 of the 2021 Society for Hematopathology and the European Association for Haematopathology Workshop aimed to collect examples of transdifferentiation, lineage infidelity, progression, and transformation in precursor and mature T/natural killer (NK)–cell neoplasms. Methods: Twenty-eight cases were submitted and analyzed, with whole-exome sequencing and genome-wide RNA expression analysis performed in a subset of the cases. Results: In session 8, 7 T-lymphoblastic lymphoma/leukemia cases were received that showed transdifferentiation to clonally related mature myeloid hematopoietic neoplasms, including 6 histiocytic/dendritic cell lineage neoplasms and a mast cell sarcoma. Session 9 included 21 mature T-cell neoplasms that were grouped into 3 themes. The first one addressed phenotypic infidelity in mature T-cell lymphomas (TCLs) and included 8 TCLs expressing aberrant antigens, mimicking classic Hodgkin and non-Hodgkin B-cell lymphomas. The second theme addressed disease progression in TCL and included 5 cutaneous T-cell lymphoproliferative disorders and 2 T-cell large granular lymphocyte proliferations with subsequent progression to systemic TCL. The third theme included 6 patients with TCL with T-follicular helper phenotype, mainly angioimmunoblastic T-cell lymphoma, with concurrent/subsequent clonal hematopoiesis or myeloid neoplasms and/ or subsequent/concomitant diffuse large B-cell lymphoma. Conclusions: This cohort of cases allowed us to illustrate, discuss, and review current concepts of transdifferentiation, aberrant antigen expression, and progression in various T/ NK-cell neoplasms.
AB - Objectives: Sessions 8 and 9 of the 2021 Society for Hematopathology and the European Association for Haematopathology Workshop aimed to collect examples of transdifferentiation, lineage infidelity, progression, and transformation in precursor and mature T/natural killer (NK)–cell neoplasms. Methods: Twenty-eight cases were submitted and analyzed, with whole-exome sequencing and genome-wide RNA expression analysis performed in a subset of the cases. Results: In session 8, 7 T-lymphoblastic lymphoma/leukemia cases were received that showed transdifferentiation to clonally related mature myeloid hematopoietic neoplasms, including 6 histiocytic/dendritic cell lineage neoplasms and a mast cell sarcoma. Session 9 included 21 mature T-cell neoplasms that were grouped into 3 themes. The first one addressed phenotypic infidelity in mature T-cell lymphomas (TCLs) and included 8 TCLs expressing aberrant antigens, mimicking classic Hodgkin and non-Hodgkin B-cell lymphomas. The second theme addressed disease progression in TCL and included 5 cutaneous T-cell lymphoproliferative disorders and 2 T-cell large granular lymphocyte proliferations with subsequent progression to systemic TCL. The third theme included 6 patients with TCL with T-follicular helper phenotype, mainly angioimmunoblastic T-cell lymphoma, with concurrent/subsequent clonal hematopoiesis or myeloid neoplasms and/ or subsequent/concomitant diffuse large B-cell lymphoma. Conclusions: This cohort of cases allowed us to illustrate, discuss, and review current concepts of transdifferentiation, aberrant antigen expression, and progression in various T/ NK-cell neoplasms.
KW - Acute lymphoblastic leukemia
KW - Clonal evolution
KW - Clonal hematopoiesis
KW - T-ALL
KW - T-cell lymphoma
KW - Transdifferentiation
KW - Transformation
UR - http://www.scopus.com/inward/record.url?scp=85161663173&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000984986800001&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1093/ajcp/aqad045
DO - 10.1093/ajcp/aqad045
M3 - Review article
C2 - 37167533
SN - 0002-9173
VL - 159
SP - 626
EP - 637
JO - American Journal of Clinical Pathology
JF - American Journal of Clinical Pathology
IS - 6
ER -